GKOS vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

GKOS

39.0
AI Score
VS
ICU Wins

ICU

60.7
AI Score

Investment Advisor Scores

GKOS

39score
Recommendation
SELL

ICU

61score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GKOS ICU Winner
Forward P/E 2000 0 Tie
PEG Ratio 1.64 0 Tie
Revenue Growth 49.5% 82.0% ICU
Earnings Growth 1896.3% 0.0% GKOS
Tradestie Score 39.0/100 60.7/100 ICU
Profit Margin -30.7% 0.0% ICU
Beta 1.00 1.00 Tie
AI Recommendation SELL STRONG BUY ICU

Relative Price Performance (Last 90 Days)

GKOS 1M: -10.4% · 3M: +34.6% ICU 1M: -9.8% · 3M: +11.0%

Current Technical Phase

GKOS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.0 · Price: $167.25

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $3.03

Fundamentals Snapshot

Metric GKOS ICU
Market Cap
Forward P/E 331.7 -1.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.5% 0.8%
Gross Margin 0.8% 0.9%
Operating Margin -0.1% -6.2%
EPS -3.10 -1.89
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.